Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
نویسندگان
چکیده
BACKGROUND Behçet's disease (BD)-associated uveitis causes retinal damage leading to severe visual disturbance. The early morphological changes in the retina are revealed by disappearance or disruption of the external limiting membrane (ELM), inner segment ellipsoid zone (EZ) and cone interdigitation zone (CIZ) in the outer retina shown on spectral domain-optical coherence tomography (SD-OCT). However, it is unknown whether these changes in the retina are reversible in BD-associated uveitis. CASE PRESENTATION A 38-year-old man was referred to our hospital with 5 years history of panuveitis in both eyes. Recurrent oral ulcer, folliculitis, and genital ulcer were noted as systemic complications. Moderate cell infiltration into the anterior chamber, and diffuse vitritis were observed in both eyes, and best corrective visual acuity (BCVA) was 20/60 in the right and 20/200 in the left eye. Fluorescein angiography (FA) showed severe dye leakage from extensive retinal vessels in both eyes. Spectral domain-optical coherence tomography (SD-OCT) revealed retinal cysts and disruption of the external limiting membrane (ELM), inner segment ellipsoid zone (EZ) and cone interdigitation zone (CIZ) in the macular region of both eyes. BD was diagnosed based on the ocular features and systemic lesions, and infliximab therapy was initiated for the severe visual disturbance. After treatment with infliximab, foveal excavation was first recovered with disappearance of retinal cysts, and then ELM and EZ were gradually reconstituted on SD-OCT. Finally, CIZ became distinguishable after 24 months of infliximab therapy. BCVA was recovered to 20/25 in both eyes, and ocular inflammatory attack did not recur after the initiation of infliximab therapy. CONCLUSION Disruption of ELM, EZ, and CIZ shown on SD-OCT in BD-associated uveitis could be reconstituted by continuous infliximab treatment, which leaded to the improvement of visual acuity.
منابع مشابه
Ciliary body metastasis masquerading as scleritis.
of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82:60–76. 10 Mousa AR, Marafie AA, Rifai KM, et al. Behçet’s disease in Kuwait, Arabia. A report of 29 cases and a review. Scand J Rheumatol 1986;15:310–32. 11 Atmaca LS. Fundus changes associated with Behçet’s disease. Graefes Arch Clin Exp Ophthalmol 1989;227:340–4. 12 Tugal...
متن کاملBotulinum toxin-induced acute anterior uveitis in a patient with Behçet’s disease under infliximab treatment: a case report
BACKGROUND Injections of lipopolysaccharide in animal models generate acute anterior uveitis (also known as endotoxin-induced uveitis), but the effects of lipopolysaccharide injection are unknown in humans. We describe an unusual case in which acute anterior uveitis was dramatically activated subsequent to botulinum toxin injection in a patient with Behçet's disease but the acute anterior uveit...
متن کاملBehçet's disease: global epidemiology of an Old Silk Road disease.
B ehçet’s disease is a multisystem disorder named after the Turkish dermatologist, Hulusi Behçet (1889–1948), who recognised and reported in 1937 a triad of symptoms consisting of recurrent eye inflammation, oral ulcers and genital ulcers. The disease had also been alluded to in descriptions by physicians as far back as Hippocrates. Behçet’s disease is particularly common in the Far East and th...
متن کاملBehçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
B ehçet’s syndrome is a chronic, relapsing, multisystemic, inflammatory disorder. The diagnosis of Behçet’s syndrome is based on clinical criteria and no pathognomonic laboratory findings exist. A diagnosis is made by the presence of recurrent oral ulceration, the hallmark of this disease, plus any two of the following: recurrent genital ulcerations, ocular lesions (anterior or posterior uveiti...
متن کاملTiming of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.
AIM To investigate the relationship between recurrence of uveitis and timing of infliximab in patients with Behçet's disease. METHODS Charts were retrospectively reviewed for 23 patients with refractory uveoretinitis associated with Behçet's disease treated using infliximab at our hospital. Infliximab was administered by intravenous infusion at weeks 0, 2 and 6, and every 8 weeks thereafter. ...
متن کامل